IL2 and neoplasm: To improve the viral delivery and reduce the host-antiviral immune response, carrier cells have been used as the viral delivery system, including adipose tissue-derived MSCs, irradiated tumor cells, interleukin-2 (IL-2) expanded T cells, and CD14+ monocytes.25